Ra Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 07, 2019 at 04:23 pm IST
Ra Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating loss was USD 22.847 million compared to USD 16.126 million a year ago. Net loss was USD 21.897 million compared to USD 15.746 million a year ago. Basic loss per share was USD 0.52 compared to USD 0.49 a year ago. For the half year, operating loss was USD 42.936 million compared to USD 32.850 million a year ago. Net loss was USD 40.936 million compared to USD 32.244 million a year ago. Basic loss per share was USD 0.97 compared to USD 1.08 a year ago.